Macular choroidal volume changes after intravitreal bevacizumab for exudative age-related macular degeneration
Retina Nov 29, 2017
Palkovits S, et al. - The upshot of intravitreal bevacizumab on the macular choroidal volume and the subfoveal choroidal thickness was inspected in this trial, in the treatment of naive eyes with exudative age-related macular degeneration. A prominent decrease was reported in the macular choroidal volume and the subfoveal choroidal thickness after 3 monthly bevacizumab injections for exudative age-related macular degeneration.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
